GBD 2019 Stroke Collaborators, Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 20(10), 795–820 (2021)
S. Wu, B. Wu, M. Liu et al. Stroke in China: advances and challenges in epidemiology, prevention, and management. Lancet Neurol. 18(4), 394–405 (2019)
G. Hindy, G. Engstrom, S.C. Larsson et al. Role of blood lipids in the development of ischemic stroke and its subtypes: a Mendelian randomization study. Stroke 49(4), 820–827 (2018)
Article CAS PubMed PubMed Central Google Scholar
M.A. Olamoyegun, A.T. Akinlade, M.B. Fawale, A.O. Ogbera, Dyslipidaemia as a risk factor in the occurrence of stroke in Nigeria: prevalence and patterns. Pan Afr. Med. J. 25, 72 (2016)
Article PubMed PubMed Central Google Scholar
J. Djelilovic-Vranic, A. Alajbegovic, V. Zelija-Asimi et al. Predilection role diabetes mellitus and dyslipidemia in the onset of ischemic stroke. Med. Arch. 67(2), 120–123 (2013)
P. Arora, R. Kalra, P.W. Callas et al. Lipoprotein(a) and risk of ischemic stroke in the REGARDS study. Arterioscler. Thromb. Vasc. Biol. 39(4), 810–818 (2019)
Article CAS PubMed PubMed Central Google Scholar
M. Dobiásová, J. Frohlich, The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FERHDL). (2001)
J.C. Fernandez-Macias, A.C. Ochoa-Martinez, J.A. Varela-Silva, I.N. Perez-Maldonado, Atherogenic index of plasma: novel predictive biomarker for cardiovascular illnesses. Arch. Med. Res. 50(5), 285–294 (2019)
Article CAS PubMed Google Scholar
J.S. Nam, M.K. Kim, K. Park et al. The plasma atherogenic index is an independent predictor of arterial stiffness in healthy Koreans. Angiology 73(6), 514–519 (2022)
Article CAS PubMed Google Scholar
M.R.K. Dobiásová, H. Rauchová, B. Vohnout, K. Ptácková, J. Frohlich, Atherogenic lipoprotein profile in families with and without history of early myocardial infarction. Physiol. Res. 2001(1), 1–8 (2001)
J.J. Kim, J. Yoon, Y.J. Lee, B. Park, D.H. Jung, Predictive value of the atherogenic index of plasma (AIP) for the risk of incident ischemic heart disease among non-diabetic Koreans. Nutrients 13(9), 3231 (2021)
A. Onat, G. Can, H. Kaya, G. Hergenc, “Atherogenic index of plasma” (log10 triglyceride/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events. J. Clin. Lipido. 4(2), 89–98 (2010)
Y. Zhang, S. Chen, X. Tian, et al. Association between cumulative atherogenic index of plasma exposure and risk of myocardial infarction in the general population. Cardiovasc. Diabetol. 22(1), 210 (2023)
C. Ma, M.E. Gurol, Z. Huang et al. Low-density lipoprotein cholesterol and risk of intracerebral hemorrhage: a prospective study. Neurology 93(5), e445–e457 (2019)
Article CAS PubMed PubMed Central Google Scholar
Y. Wang, A. Wang, Y. Zuo, S. Wu, X. Zhao, Two-year change in serum total cholesterol is associated with incident ischemic stroke: results from the Kailuan study. Front. Neurol. 12, 710083 (2021)
Article PubMed PubMed Central Google Scholar
L. Kopin, C. Lowenstein, Dyslipidemia. Ann. Intern. Med. 167(11), ITC81–ITC96 (2017)
F. Crea, Dyslipidaemias in stroke, chronic kidney disease, and aortic stenosis: the new frontiers for cholesterol lowering. Eur. Heart J. 42(22), 2137–2140 (2021)
Article CAS PubMed Google Scholar
H. Liu, K. Liu, L. Pei et al. Atherogenic index of plasma predicts outcomes in acute ischemic stroke. Front. Neurol. 12, 741754 (2021)
Article PubMed PubMed Central Google Scholar
C. Wang, Z. Du, N. Ye et al. Using the atherogenic index of plasma to estimate the prevalence of ischemic stroke within a general population in a rural area of China. Biomed. Res. Int. 2020, 7197054 (2020)
Article PubMed PubMed Central Google Scholar
T.T. Wu, Y. Gao, Y.Y. Zheng, Y.T. Ma, X. Xie, Atherogenic index of plasma (AIP): a novel predictive indicator for the coronary artery disease in postmenopausal women. Lipids Health Dis. 17(1), 197 (2018)
Article PubMed PubMed Central Google Scholar
Y. Zheng, C. Li, J. Yang et al. Atherogenic index of plasma for non-diabetic, coronary artery disease patients after percutaneous coronary intervention: a prospective study of the long-term outcomes in China. Cardiovasc. Diabetol. 21(1), 29 (2022)
Article CAS PubMed PubMed Central Google Scholar
L. Fu, Y. Zhou, J. Sun et al. Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus. Cardiovasc. Diabetol. 20(1), 201 (2021)
Article CAS PubMed PubMed Central Google Scholar
J.S. Dron, R.A. Hegele, Genetics of triglycerides and the risk of atherosclerosis. Curr. Atheroscler. Rep. 19(7), 31 (2017)
Article PubMed PubMed Central Google Scholar
K. Murakami, A. Harada, R. Toh et al. Fully automated immunoassay for cholesterol uptake capacity to assess high-density lipoprotein function and cardiovascular disease risk. Sci. Rep. 13(1), 1899 (2023)
Article CAS PubMed PubMed Central Google Scholar
M. Dobiásová, J. Frohlich, The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin. Biochem. 34(7), 583–588 (2001)
A.H. Anderson, W. Yang, R.R. Townsend et al. Time-updated systolic blood pressure and the progression of chronic kidney disease: a cohort study. Ann. Intern. Med. 162(4), 258–265 (2015)
Article PubMed PubMed Central Google Scholar
X. Tian, Y. Zuo, S. Chen et al. Triglyceride-glucose index is associated with the risk of myocardial infarction: an 11-year prospective study in the Kailuan cohort. Cardiovasc. Diabetol. 20(1), 19 (2021)
留言 (0)